article · AIDS

Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial

Phyo Pyae Nyein
Jung-Min Ann
Dianne Carey
P. L. Drury
K Petoumenos
Josh Hanson
M. A. Kundro
Blessing Uche
R Kaplan
Nila J Dharan
Leslie Faber
Dannae Brown
Mark W Donoghoe
Nnakelu Eriobu
Gail V Matthews

2026Open accessUniversity of Cape Town

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

NCT03017872.

Research topics

HIV-related health complications and treatments
HIV/AIDS drug development and treatment
Pharmacology and Obesity Treatment

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1097/qad.0000000000004476

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.